NASDAQ: RAREUltragenyx Pharmaceutical Inc Stock Ownership - Who owns Ultragenyx Pharmaceutical?
Insider buying vs selling
Have Ultragenyx Pharmaceutical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Eric Crombez | EVP and Chief Medical Officer | 2024-04-18 | 142 | $44.10 | $6.26kSell |
| Theodore Alan Huizenga | SVP Chief Accounting Officer | 2024-04-16 | 14 | $42.31 | $592.34Sell |
| Thomas Richard Kassberg | CBO EVP | 2024-03-11 | 11,509 | $49.93 | $574.64kSell |
| Matthew K. Fust | Director | 2024-03-07 | 7,500 | $50.88 | $381.60kSell |
| Matthew K. Fust | Director | 2024-03-07 | 2,145 | $50.85 | $109.07kSell |
| Matthew K. Fust | Director | 2024-03-07 | 2,550 | $50.89 | $129.77kSell |
| Eric Crombez | EVP and Chief Medical Officer | 2024-03-01 | 1,238 | $53.76 | $66.55kSell |
| Erik Harris | EVP Chief Commercial Officer | 2024-03-01 | 4,768 | $53.76 | $256.33kSell |
| Dennis Karl Huang | EVP Chief Technical Operations Officer | 2024-03-01 | 470 | $53.69 | $25.23kSell |
| Theodore Alan Huizenga | SVP Chief Accounting Officer | 2024-03-01 | 341 | $53.76 | $18.33kSell |
RARE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RARE insiders and whales buy or sell their stock.
RARE Shareholders
What type of owners hold Ultragenyx Pharmaceutical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 10.53% | 8,673,432 | $383.71M | Institution |
| Emil D. Kakkis | 8.97% | 7,381,624 | $326.56M | Insider |
| Rtw Investments LP | 8.36% | 6,887,086 | $304.68M | Institution |
| Blackrock Inc | 6.36% | 5,238,400 | $231.75M | Institution |
| Fmr LLC | 5.73% | 4,718,234 | $208.73M | Insider |
| Wellington Management Group LLP | 5.36% | 4,415,029 | $195.32M | Institution |
| Sands Capital Management LLC | 5.00% | 4,118,008 | $182.18M | Institution |
| Price T Rowe Associates Inc | 4.19% | 3,448,698 | $152.57M | Institution |
| State Street Corp | 3.95% | 3,252,502 | $143.89M | Institution |
| Tpg Group Holdings Sbs Advisors Inc | 3.15% | 2,596,420 | $114.87M | Insider |
RARE vs Biotech Stocks
Ultragenyx Pharmaceutical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.